Glycorex Transplantation AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was SEK 8.67 million compared to SEK 9.29 million a year ago. Revenue was SEK 8.9 million compared to SEK 10.54 million a year ago. Net loss was SEK 0.488 million compared to net income of SEK 0.994 million a year ago. Basic loss per share from continuing operations was SEK 0.01 compared to basic earnings per share from continuing operations of SEK 0.01 a year ago.
For the nine months, sales was SEK 21.96 million compared to SEK 21.05 million a year ago. Revenue was SEK 22.84 million compared to SEK 21.7 million a year ago. Net loss was SEK 8.14 million compared to SEK 5.43 million a year ago. Basic loss per share from continuing operations was SEK 0.11 compared to SEK 0.07 a year ago.